One way to tackle the snakebite antivenom crisis may be through biotechnological innovation to make antivenoms more cost-effective, easier to produce, and more efficacious against snakebites.
Articles on Snakebite
Displaying 21 - 21 of 21 article
Top contributors
-
Professor & Head of Section at the Department of Biotechnology and Biomedicine, Technical University of Denmark
-
Research Fellow and Co-head, Australian Venom Research Unit, The University of Melbourne
-
Postdoctoral researcher, Department of Biotechnology and Biomedicine, Center for Antibody Technologies, Technical University of Denmark
-
Senior Lecturer and UKRI Future Leader Fellow, University of Liverpool
-
Senior Lecturer, Biodiversity and Conservation Biology, University of the Western Cape
-
Post Doctoral Researcher, Technical University of Denmark
-
Researcher at Instituto Clodomiro Picado, Universidad de Costa Rica
-
Emeritus Professor, Instituto Clodomiro Picado, Universidad de Costa Rica
-
PhD candidate: School of Animal, Plant and Environmental Sciences, University of the Witwatersrand
-
Senior Specialist, University of Pretoria
-
Lecturer, Lúrio University
-
Research fellow, Biodiversity and Conservation Biology, University of the Western Cape
-
Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne, Murdoch Children's Research Institute
-
PhD Candidate, Antibodies, Liverpool School of Tropical Medicine
-
PhD candidate in venom genomics, University of Sydney